µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© (WW*yv.J
NT qtr="
Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© /3MTutM|<X
1¡¢Co-stimulators (or co-stimulating molecules) R"j6 w[tn
2¡¢NK-kB 6usy0g
D
3¡¢Immunoglobulin superfamily t>04nN_@,s
4¡¢antigen-presenting cell (APC) o6H\JCne
5¡¢death domain V}leEf2'
6¡¢CCR and CXCR <"SDU_<xG
7¡¢Lectin (or mitogen) l7rGz2:?
8¡¢Clusters of differentiation, CD) 'rT@
r:6fn
9¡¢B7 family ?J;*
10¡¢Cytotoxic T lymphocyte, CTL) f8>S<:
11¡¢IL-15 and IL-15 receptor (IL-15R) $6~
\xe=
12¡¢MHC restriction 1[QH68
13¡¢Affinity-chromatography lX)RG*FlTC
14¡¢Cyctosprin A, CsA %-z AV*>
15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) #MZ0Sd8]&
W]
8tp@
¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© QK+s}ny
1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 4o:
2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ X%+FM]
3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ w|6;Pf~1y)
7e,EI9?.
Èý¡¢ÎÊ´ðÌ⣨25·Ö£© G$ l>By
1¡¢Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ L{>XT
ѪҺ²¡Ñ§×¨Òµ£º yFt'<{z[nL
2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿